LMX1A gene therapy: In DAnergic neuron development, Nurr1, Lmx1a, and Pitx3 are representative transcriptional factors that determine the developmental fate of DAnergic neurons and the expression of those factors is downregulated in the DAnergic neurons of PD patients [120]. This evidence concerns the gene LMX1A and Parkinson disease.